Related Experiment Video
Updated: May 9, 2026

Simultaneous Imaging and Flow-Cytometry-based Detection of Multiple Fluorescent Senescence Markers in Therapy-Induced Senescent Cancer Cells
Published on: July 12, 2022
Mitochondrial DNA damage induces apoptosis in senescent cells
R-M Laberge1, D Adler, M DeMaria
1Buck Institute for Research on Aging, Novato, CA, USA.
Abstract:
Senescence is a cellular response to damage and stress. The senescence response prevents cancer by suppressing the proliferation of cells with a compromised genome and contributes to optimal wound healing in normal tissues. Persistent senescent cells are also thought to drive aging and age-associated pathologies through their secretion of inflammatory factors that modify the tissue microenvironment and alter the function of nearby normal or transformed cells. Understanding how senescent cells alter the microenvironment would be aided by the ability to induce or eliminate senescent cells at will in vivo. Here, we combine the use of the synthetic nucleoside analog ganciclovir (GCV) with herpes simplex virus thymidine kinase (HSVtk) activity to create or eliminate senescent human cells. We show that low concentrations of GCV induce senescence through the accumulation of nuclear DNA damage while higher concentrations of GCV, similar to those used in vivo, kill non-dividing senescent cells via mitochondrial DNA (mtDNA) damage and caspase-dependent apoptosis. Using this system, we effectively eliminated xenografted normal human senescent fibroblasts or induced senescence in human breast cancer cells in vivo. Thus, cellular senescence and mtDNA damage are outcomes of synthetic nucleoside analog treatment, indicating that the GCV-HSVtk combination can be used effectively to promote the targeted formation or eradication of senescent cells.
Insights
Researchers developed a novel method to control cellular senescence using ganciclovir (GCV) and herpes simplex virus thymidine kinase (HSVtk). This system can selectively induce or eliminate senescent cells, offering new therapeutic possibilities for aging and cancer.
Area of Science:
- Cell Biology
- Molecular Biology
- Biotechnology
Background:
- Cellular senescence, a state of irreversible growth arrest, plays a dual role in preventing cancer and promoting wound healing.
- Accumulation of senescent cells is linked to aging and age-related diseases due to their inflammatory secretions.
- Targeted manipulation of senescent cells in vivo is crucial for understanding their role in disease and developing therapies.
Purpose of the Study:
- To develop a controllable system for inducing or eliminating senescent human cells in vivo.
- To investigate the mechanisms by which ganciclovir (GCV) affects senescent cells.
- To explore the therapeutic potential of targeting cellular senescence.
Main Methods:
- Utilized the synthetic nucleoside analog ganciclovir (GCV) in combination with herpes simplex virus thymidine kinase (HSVtk) activity.
- Administered low concentrations of GCV to induce senescence via nuclear DNA damage.
- Used higher concentrations of GCV to eliminate senescent cells through mitochondrial DNA (mtDNA) damage and apoptosis.
Main Results:
- Demonstrated that GCV can induce senescence at low doses by causing nuclear DNA damage.
- Showed that higher GCV doses trigger apoptosis in senescent cells via mtDNA damage and caspase activation.
- Successfully eliminated senescent human fibroblasts and induced senescence in human breast cancer cells in vivo.
Conclusions:
- The GCV-HSVtk system provides a versatile tool for targeted induction or eradication of senescent cells.
- Cellular senescence and mtDNA damage are key outcomes of GCV treatment.
- This approach holds promise for therapeutic strategies targeting senescence in aging and cancer.
Related Concept Videos
Mitochondria
Overview of DNA Repair
Chemically...
Replicative Cell Senescence
Cellular Injury V: Apoptosis and Autophagy
Apoptosis
Mitochondrial Membranes

